Spectral Computed Tomography Market
Number of pages: 100 | Report Format: PDF | Published date: May 29, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023 to 2031
|
Report Attribute |
Details |
|
Market Size Value in 2022 |
US$ 8.10 billion |
|
Revenue Forecast in 2031 |
US$ 10.82 billion |
|
CAGR |
3.26% |
|
Base Year for Estimation |
2022 |
|
Forecast Period |
2023 to 2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Indication, Product Type, Technology, End User, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global spectral computed tomography market was valued at US$ 8.10 billion in 2022 and is expected to register a revenue CAGR of 3.26% to reach US$ 10.82 billion by 2031.
Spectral Computed Tomography Market Fundamentals
Spectral Computed Tomography (CT) is an advanced imaging technique that combines the principles of traditional CT scanning with spectral imaging capabilities. Unlike conventional CT, which measures X-ray attenuation only, spectral CT can provide additional information about the energy characteristics of the X-ray beam. This enables the differentiation of materials with similar attenuation coefficients but different energy-dependent properties. Spectral CT systems use specific detectors or techniques to measure the energy spectrum of X-ray photons passing through the body. This spectral information can be used to generate images that reveal more detailed anatomical and functional information, leading to improved diagnostic accuracy and expanded clinical applications.
Spectral Computed Tomography Market Dynamics
Continuous advancements in imaging technology, such as photon-counting detectors and dual-source systems, are driving the adoption of spectral CT. These advancements enable improved image quality, faster scan times, and expanded clinical applications, leading to better diagnostic accuracy and patient outcomes. The shift towards personalized medicine drives the demand for imaging techniques that provide detailed tissue composition and function information. The rising incidence of chronic diseases, such as cardiovascular disorders and cancer, is fueling the demand for advanced imaging techniques like spectral CT. As with any new technology, the cost of spectral CT systems is gradually decreasing, making them more accessible to a broader range of healthcare facilities. This cost reduction, improved efficiency, and clinical benefits make spectral CT a viable option for many healthcare providers.
Spectral CT systems are generally more expensive than conventional CT scanners. The high cost of acquisition, installation, and maintenance can be a significant barrier to adoption, particularly for smaller healthcare facilities with limited budgets. Cost-effectiveness and return on investment considerations may limit the widespread implementation of Spectral CT technology. Moreover, managing radiation exposure while maintaining image quality and diagnostic accuracy is a critical challenge. Ongoing research focuses on optimizing scanning protocols and dose-reduction techniques to address this concern. Establishing standards and achieving interoperability between different spectral CT systems remain ongoing challenges that need to be addressed for seamless data exchange and collaboration. Despite the potential benefits, there is still a need for further clinical evidence and studies to establish the clinical utility, cost-effectiveness, and improved patient outcomes associated with spectral CT.
Spectral Computed Tomography Market Ecosystem
The global spectral computed tomography market has been analyzed from five perspectives: by indication, product type, technology, end user, and region.
Spectral Computed Tomography Market by Indication
Based on the indication, the global spectral computed tomography market is segmented into oncology, cardiological diseases, neurological diseases, urological diseases, musculoskeletal disorders, and others.
The oncology segment dominates the global market with the largest revenue share. Cancer is a significant global health burden, highly prevalent across various regions. Oncology imaging plays a crucial role in cancer patients diagnosis, staging, treatment planning, and monitoring. According to “The American Cancer Society Journal,” in 2020, there will be an estimated 19.3 million new cancer diagnoses and 10 million cancer deaths globally. Spectral CT enables better visualization and characterization of tumors compared to conventional CT. It can differentiate between tumor tissues, surrounding normal tissues, and adjacent structures more accurately, aiding in assessing tumor size, location, and extent. This information is vital for treatment planning, including surgical interventions, radiation therapy, and targeted therapies. Spectral CT's quantitative analysis capabilities, such as measuring contrast agent uptake and perfusion, facilitate the assessment of treatment response in cancer patients. It allows clinicians to evaluate changes in tumor vascularity, necrosis, and metabolic activity, assisting in monitoring the effectiveness of chemotherapy, targeted therapies, and other interventions. Cancer is known for its intra tumoral heterogeneity, where different tumor regions have varying characteristics. This information can assist in identifying aggressive tumor subtypes, predicting treatment response, and guiding personalized treatment approaches. Spectral CT's virtual non-contrast imaging capability allows clinicians to generate non-contrast images from contrast-enhanced scans. This eliminates the need for a separate non-contrast scan, reducing patient radiation exposure and the need for additional scans. This feature can be particularly beneficial in oncology, where patients often require repeated imaging during treatment follow-ups. Spectral CT technology has seen significant research and development efforts in the oncology field. Numerous studies have demonstrated its potential benefits in areas such as tumor characterization, response assessment, and prediction of treatment outcomes. This focus on oncology applications has contributed to the dominance of the oncology segment in the spectral CT market.
Spectral Computed Tomography Market by Product Type
Based on the product type, the global spectral computed tomography market is segmented into spiral CT, electron beam tomography, and multi-slice computed tomography.
Electron beam tomography segment accounts for notable revenue shares in the global market. Electron beam tomography (EBT) is a specific type of CT technology that utilizes a focused electron beam instead of an X-ray beam to generate images. EBT was primarily used for coronary artery calcium scoring, which is a method to assess the presence and extent of calcium deposits in the coronary arteries. However, the usage of EBT technology has become comparatively less prevalent in recent years due to advancements in conventional CT scanners that can also perform calcium scoring.
Spectral Computed Tomography Market by Technology
Based on the phase, the global spectral computed tomography market is segmented into dual-layer detector and gemstone spectral imaging detector.
Dual-layer segment accounts for a sizeable revenue share in the global market. Dual-layer detectors enable dual-energy imaging, which involves simultaneously acquiring two sets of images at different energy levels. This technique provides additional information about tissue composition, contrast enhancement, and material differentiation. It allows for enhanced tissue characterization, identification of contrast agents, and the detecting of subtle abnormalities that may not be visible on conventional CT scans. Dual-layer detectors can mitigate beam-hardening artifacts, which are common in conventional CT scans. These artifacts arise due to the different energy-dependent attenuation properties of various materials. By acquiring images at different energy levels, dual-layer detectors can correct these artifacts and improve image quality, improving diagnostic accuracy and confidence. Dual-layer detectors offer a simplified workflow compared to other spectral imaging techniques. Instead of requiring multiple scans or additional equipment, dual-energy imaging can be performed in a single acquisition using a dual-layer detector. This streamlined workflow saves time, reduces patient discomfort, and enhances efficiency in clinical practice.
Spectral Computed Tomography Market by End User
Based on the phase, the global spectral computed tomography market is segmented into hospitals, private clinics, diagnostic and imaging centers, academic institutes and research centers, and others.
The hospitals segment leads the global market with the largest revenue share of around 40%. Hospitals are equipped to provide comprehensive medical services, including advanced imaging technologies like spectral CT. With a wide range of clinical departments and specialties, hospitals cater to diverse patient needs, making them a primary setting for implementing and utilizing advanced imaging technologies. Hospitals generally have a higher patient volume compared to other healthcare facilities. Hospitals need to handle a broad spectrum of medical conditions, making advanced imaging techniques valuable for accurate diagnosis, treatment planning, and monitoring. Hospitals often have specialized medical professionals, including radiologists, oncologists, cardiologists, and other specialists, who require advanced imaging technologies to support their diagnostic and treatment decisions. Hospitals typically have the infrastructure, resources, and financial capabilities to invest in and maintain advanced imaging technologies. Many hospitals are affiliated with research and academic institutions, fostering a culture of innovation and technology adoption. Hospitals often act as patient referral centers, receiving referrals from primary care physicians, outpatient clinics, and other healthcare facilities. Hospitals aim to provide comprehensive patient care, offering various diagnostic and treatment services under one roof. Incorporating advanced imaging technologies like Spectral CT enables hospitals to deliver a more comprehensive and integrated approach to patient care, improving patient outcomes and satisfaction.
Spectral Computed Tomography Market by Region
Based on the region, the global spectral computed tomography market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
North America dominates the global market with the largest revenue. North America has a well-developed and advanced healthcare infrastructure, with a high concentration of hospitals, imaging centers, and medical facilities. This infrastructure provides a conducive environment for adopting and utilizing advanced imaging technologies like Spectral CT. The region is known for its leadership in medical technology and innovation. North American countries, particularly the United States, have a strong presence of leading medical device manufacturers, research institutions, and academic centers that drive advancements in imaging technology, including spectral CT. This technological leadership contributes to the region's widespread availability and adoption of spectral CT systems. North America has one of the highest healthcare expenditure levels globally. This significant investment in healthcare infrastructure, research, and technology creates a favorable market environment for adopting advanced imaging technologies. The availability of robust reimbursement systems in North America plays a role in adopting advanced imaging technologies. Adequate reimbursement for spectral CT procedures encourages healthcare providers to invest in and offer these services, making them more accessible to patients and driving the market growth. North America is a hub for medical research and clinical trials. This research environment fosters collaborations between industry, academia, and healthcare institutions, leading to the advancement and validation of new imaging technologies. North America has well-established regulatory frameworks for medical devices, including imaging technologies. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) provide clear pathways for market clearance and approval of Spectral CT systems. This regulatory support facilitates the commercialization and widespread availability of Spectral CT in North America.
Competitive Landscape
The prominent players operating in the global spectral computed tomography market are:
Neusoft Medical Systems Co. Ltd., GE Healthcare, Koninklijke Philips N.V., and Siemens Healthcare are some of the major market players in the global spectral computed tomography market.
Limited availability and lack of clinical evidence are some of the restraints obstructing the growth of the global market.
Spectral computed tomography (CT), also known as dual-energy computed tomography (DECT), is a type of computed tomography that is widely utilized in X-ray scanning procedures. Rather than employing one large energy band for X-rays, it divides the energy into two or more small energy bands. Different bodily tissues respond differently to energy bands.
The oncology segment dominates the global spectral computed tomography market.
The growing prevalence of chronic disease and the growing demand for personalized medicine are some of the major factors driving the global market.
*Insights on financial performance is subject to availability of information in public domain